Merck Must Disclose All Health Risk Studies in NuvaRing Lawsuits

Share Article

The NuvaRing Resource Center is the Web’s largest source for information on NuvaRing side effects, research and legal news. Visit http://www.NuvaRing-Lawsuits.net

Nuvaring lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after using NuvaRing is urged to contact the NuvaRing Resource Center or speak with a lawyer about their legal options.

A federal judge overseeing NuvaRing lawsuits over blood clots recently ordered (PDF) that drug maker Merck must disclose all NuvaRing studies which had previously been sealed. According to Yahoo News, this could harm the manufacturer’s case in trials which will start on May 6, 2013. http://cdn.aboutlawsuits.com/wp-content/uploads/2012-10-25-NuvaRing-Order.pdf

The latest news comes as experts warn that NuvaRing may increase risks of blood clot risks and the FDA reports it has received more than 1,000 complaints of blood clot injury or death among patients using NuvaRing, according to CBS News San Diego on September 21, 2012.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after using NuvaRing is urged to contact the NuvaRing Resource Center or speak with a lawyer about their legal options.

The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.

Last October, the FDA issued a report titled, "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints", which showed vaginal ring contraceptives could increase the risks of blood clots by as much as 56%.

Due to the number of NuvaRing lawsuits filed, the cases have been consolidated into a federal Multi-District Litigation court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. On September 5, 2012, the U.S. Panel on Multidistrict Litigation indicated that more than 1,000 cases have been filed so far.

The NuvaRing Resource Center urges anyone affected by blood clots, stroke, DVT or pulmonary embolism after using NuvaRing to learn their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, the Resource Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on research, side effects and litigation news related to NuvaRing devices, or to speak with a lawyer, visit http://www.NuvaRing-Lawsuits.net.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website